Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Diseases | 4 | 2016 | 138 | 1.060 |
Why?
|
| Occupational Diseases | 3 | 2014 | 83 | 1.000 |
Why?
|
| Hispanic Americans | 5 | 2016 | 904 | 0.990 |
Why?
|
| Meat-Packing Industry | 2 | 2014 | 10 | 0.960 |
Why?
|
| Pruritus | 2 | 2017 | 58 | 0.670 |
Why?
|
| Skin Neoplasms | 4 | 2013 | 206 | 0.630 |
Why?
|
| Vulva | 1 | 2017 | 1 | 0.630 |
Why?
|
| Vulvar Diseases | 1 | 2017 | 2 | 0.630 |
Why?
|
| Alopecia | 1 | 2018 | 25 | 0.620 |
Why?
|
| Pyrroles | 1 | 2018 | 55 | 0.620 |
Why?
|
| Pyrimidines | 1 | 2018 | 60 | 0.610 |
Why?
|
| Alopecia Areata | 1 | 2017 | 16 | 0.610 |
Why?
|
| Methotrexate | 1 | 2017 | 60 | 0.600 |
Why?
|
| Piperidines | 1 | 2018 | 125 | 0.590 |
Why?
|
| Skin | 2 | 2016 | 203 | 0.580 |
Why?
|
| Dermatitis, Atopic | 1 | 2017 | 86 | 0.550 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 180 | 0.520 |
Why?
|
| Ethnic Groups | 2 | 2015 | 440 | 0.520 |
Why?
|
| Tinea Pedis | 1 | 2014 | 6 | 0.500 |
Why?
|
| Onychomycosis | 1 | 2014 | 9 | 0.500 |
Why?
|
| Melanoma | 2 | 2013 | 148 | 0.490 |
Why?
|
| Emigrants and Immigrants | 2 | 2014 | 235 | 0.490 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2014 | 8 | 0.490 |
Why?
|
| Dermatologic Agents | 1 | 2017 | 208 | 0.480 |
Why?
|
| Facial Dermatoses | 1 | 2014 | 19 | 0.480 |
Why?
|
| Adolescent | 8 | 2018 | 3254 | 0.400 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 430 | 0.400 |
Why?
|
| Humans | 20 | 2018 | 29093 | 0.370 |
Why?
|
| Melanosis | 1 | 2009 | 13 | 0.340 |
Why?
|
| Cryoglobulinemia | 1 | 2008 | 5 | 0.330 |
Why?
|
| Skin Ulcer | 1 | 2008 | 10 | 0.320 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2008 | 12 | 0.320 |
Why?
|
| Female | 13 | 2017 | 18164 | 0.310 |
Why?
|
| Quality of Life | 2 | 2013 | 816 | 0.310 |
Why?
|
| Cellulitis | 1 | 2007 | 11 | 0.310 |
Why?
|
| Eosinophilia | 1 | 2007 | 16 | 0.300 |
Why?
|
| Adult | 9 | 2018 | 8420 | 0.290 |
Why?
|
| Male | 13 | 2018 | 17807 | 0.270 |
Why?
|
| Transients and Migrants | 1 | 2009 | 281 | 0.270 |
Why?
|
| North Carolina | 4 | 2016 | 1423 | 0.260 |
Why?
|
| Cross-Sectional Studies | 3 | 2014 | 1356 | 0.240 |
Why?
|
| Poultry | 2 | 2014 | 29 | 0.240 |
Why?
|
| Young Adult | 4 | 2014 | 2402 | 0.220 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 863 | 0.190 |
Why?
|
| Prevalence | 2 | 2013 | 896 | 0.160 |
Why?
|
| Hair | 1 | 2018 | 28 | 0.160 |
Why?
|
| Scalp | 1 | 2018 | 33 | 0.160 |
Why?
|
| Dermatitis, Contact | 1 | 2017 | 11 | 0.160 |
Why?
|
| Patients | 1 | 2017 | 46 | 0.150 |
Why?
|
| Health Care Surveys | 2 | 2015 | 176 | 0.150 |
Why?
|
| Food-Processing Industry | 2 | 2013 | 41 | 0.150 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 493 | 0.140 |
Why?
|
| Health Services Research | 1 | 2016 | 78 | 0.140 |
Why?
|
| Medication Adherence | 1 | 2017 | 144 | 0.130 |
Why?
|
| Diabetes Complications | 1 | 2016 | 171 | 0.130 |
Why?
|
| Dermatitis, Occupational | 1 | 2013 | 10 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 231 | 0.120 |
Why?
|
| Child, Preschool | 1 | 2017 | 1167 | 0.120 |
Why?
|
| Latin America | 1 | 2013 | 9 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 366 | 0.110 |
Why?
|
| Animals | 3 | 2014 | 7297 | 0.110 |
Why?
|
| Emigration and Immigration | 1 | 2013 | 32 | 0.110 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2013 | 86 | 0.110 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2012 | 14 | 0.110 |
Why?
|
| Fibroma | 1 | 2012 | 11 | 0.110 |
Why?
|
| Child | 2 | 2017 | 2219 | 0.110 |
Why?
|
| Comorbidity | 1 | 2014 | 540 | 0.110 |
Why?
|
| Sex Factors | 1 | 2014 | 631 | 0.110 |
Why?
|
| Skin Pigmentation | 1 | 2012 | 23 | 0.110 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2012 | 90 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2017 | 3111 | 0.100 |
Why?
|
| Dermatology | 1 | 2013 | 154 | 0.100 |
Why?
|
| Middle Aged | 5 | 2013 | 10829 | 0.100 |
Why?
|
| Continental Population Groups | 1 | 2012 | 221 | 0.100 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2009 | 69 | 0.090 |
Why?
|
| European Continental Ancestry Group | 1 | 2015 | 1131 | 0.090 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 2009 | 6 | 0.090 |
Why?
|
| Risk Factors | 2 | 2014 | 3531 | 0.090 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2009 | 10 | 0.090 |
Why?
|
| United States | 2 | 2015 | 3630 | 0.090 |
Why?
|
| Mastocytosis, Cutaneous | 1 | 2008 | 3 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 2009 | 87 | 0.080 |
Why?
|
| Probability | 1 | 2009 | 150 | 0.080 |
Why?
|
| Neurodermatitis | 1 | 2008 | 1 | 0.080 |
Why?
|
| Amyloidosis | 1 | 2008 | 10 | 0.080 |
Why?
|
| Age Distribution | 1 | 2009 | 198 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2009 | 454 | 0.080 |
Why?
|
| Cetirizine | 1 | 2007 | 2 | 0.080 |
Why?
|
| Anti-Allergic Agents | 1 | 2007 | 7 | 0.080 |
Why?
|
| African Americans | 1 | 2015 | 1373 | 0.080 |
Why?
|
| Blister | 1 | 2007 | 7 | 0.080 |
Why?
|
| Prednisone | 1 | 2007 | 43 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2007 | 169 | 0.070 |
Why?
|
| Recurrence | 1 | 2007 | 235 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 720 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 273 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 90 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2007 | 92 | 0.070 |
Why?
|
| Aged | 4 | 2013 | 9487 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2009 | 3717 | 0.070 |
Why?
|
| Intraoperative Care | 2 | 2009 | 48 | 0.040 |
Why?
|
| Chickens | 1 | 2012 | 40 | 0.030 |
Why?
|
| Fingers | 1 | 2012 | 57 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2012 | 96 | 0.030 |
Why?
|
| Age Factors | 1 | 2013 | 1108 | 0.020 |
Why?
|
| Rosaniline Dyes | 1 | 2009 | 19 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2009 | 30 | 0.020 |
Why?
|
| Silver Sulfadiazine | 1 | 2008 | 4 | 0.020 |
Why?
|
| Fluocinonide | 1 | 2008 | 11 | 0.020 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2008 | 13 | 0.020 |
Why?
|
| Mast Cells | 1 | 2008 | 17 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2008 | 24 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2008 | 9 | 0.020 |
Why?
|
| Epidermis | 1 | 2008 | 23 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 2008 | 30 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2008 | 149 | 0.020 |
Why?
|
| Frozen Sections | 1 | 2007 | 18 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 2007 | 19 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 787 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 156 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2007 | 89 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 281 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 436 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 532 | 0.020 |
Why?
|
| Infant | 1 | 2008 | 969 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 795 | 0.020 |
Why?
|
| Aging | 1 | 2008 | 881 | 0.010 |
Why?
|